Two Doctors from Shonan AGA Clinic Present Research Findings at the 30th Annual Meeting of the Japanese Society of Clinical Hair Restoration
Sharing Clinical Research That Looks Ahead to the Future of Hair Medicine: Presenting an Evidence-Based Treatment Framework and New Possibilities in Regenerative Medicine
IRVINE, Calif. -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced that Dr. Koichi Saito, Director of Shonan AGA Clinic Shinjuku Main Branch, and Dr. Keiichiro Kasai, Director of Shonan AGA Clinic Shinjuku Southern Terrace Branch—both clinics supported by SBC Medical—presented their research findings at the 30th Annual Meeting of the Japanese Society of Clinical Hair Restoration.
The Japanese Society of Clinical Hair Restoration is one of Japan’s largest academic organizations dedicated to the advancement of hair science and regenerative medicine, providing a platform for sharing the latest research and promoting clinical applications in the field. The 30th Annual Meeting, held over two days from November 8, 2025, was organized under the theme “Into the Future: Integration of Basic and Clinical Research,” bringing together medical institutions, researchers, and industry partners to present cutting-edge findings in areas such as regenerative medicine, stem cell research, and hair transplantation technologies.
At this year’s meeting, two physicians from Shonan AGA Clinic were selected to present, in recognition of their academic contributions and clinical achievements.
Dr. Koichi Saito, Director of the Shinjuku Main Branch, highlighted the unique characteristics of hair flow patterns commonly seen in Japanese men and discussed techniques for improving design precision and achieving more natural results in hair transplantation. His presentation, grounded in extensive clinical experience, emphasized individualized approaches to guide patients toward optimal hair restoration outcomes and drew considerable attention from attendees. Dr. Keiichiro Kasai, Director of the Shinjuku Southern Terrace Branch, presented on the clinical application of umbilical cord–derived stem cell conditioned media, reporting on the potential of regenerative medicine–based therapies for hair restoration. Using real-world clinical data, he outlined prospects for safety and efficacy, offering new insights into the development of next-generation therapeutic approaches. Both presentations demonstrated how clinical insights can be scientifically validated to drive innovation in the field of hair regeneration. By examining safety profiles and reproducibility based on clinical data, the physicians highlighted emerging possibilities for advanced treatment strategies.
The fields of hair restoration and transplantation extend beyond aesthetic improvement; they play a significant role in supporting patients’ quality of life (QOL) and psychological well-being. At SBC Medical Group, we regard these areas as forward-looking medical domains and are committed to establishing safe and sustainable treatment systems based on scientific evidence. We will continue advancing knowledge-sharing and academic collaboration through conference presentations and clinical research, contributing to the development of new standards in hair medicine.
Overview of the 30th Annual Meeting of the Japanese Society of Clinical Hair Restoration
Venue: TKP Garden City Ochanomizu
Dates: November 8 (Sat) – November 9 (Sun), 2025
Official Website: https://shun-convention.jp/jschr2025/index.html
Presentation Titles
Dr. Koichi Saito (Director, Shonan AGA Clinic Shinjuku Main Branch)
Characteristics of Occipital Hair Flow and Cowlick Patterns in Japanese Men:
Clinical Insights for Enhancing Hair Transplantation Design
Dr. Keiichiro Kasai (Director, Shonan AGA Clinic Shinjuku Southern Terrace Branch)
Evaluating the Hair Regeneration Effects of Umbilical Cord–Derived Stem Cell Conditioned Media:
Assessment of Reproducibility and Safety Through Additional Clinical Cases
After graduating from Mie University Faculty of Medicine, Dr. Koichi Saito began his career in neurosurgery before transitioning into the field of hair medicine. Since joining Shonan Beauty Clinic in 2009, he has presented numerous clinical studies on AGA treatment and autologous hair transplantation. Dr. Saito is known for his personalized, patient-specific treatment approach and his commitment to achieving highly reproducible outcomes grounded in scientific evidence.
As Director of the Shinjuku Main Branch, he continues to contribute to the advancement of hair medicine through his work in research, education, and clinical practice.
For more details on Dr. Saito’s profile, please click here.
After graduating from Shimane Medical University School of Medicine, Dr. Keiichiro Kasai worked as a neurosurgeon at Toho University Ohashi Medical Center. He later pursued further training overseas at Aix-Marseille University in France and the University of Chicago in the United States, where he gained advanced skills in international medical settings.
Since joining Shonan Beauty Clinic in 2009, Dr. Kasai has specialized in autologous hair transplantation and regenerative medicine, accumulating over 3,000 clinical cases. Leveraging his precise technique and extensive expertise, he is dedicated to achieving natural-looking and highly reproducible results in hair restoration.
For more details on Dr. Kasai’s profile, please click here.
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com/
Contacts
SBC Medical Group Holdings Incorporated (Asia)
Hikaru Fukui / Head of Investor Relations E-mail: ir@sbc-holdings.com
Daisuke Murakami / Public Relations Officer E-mail: pr@sbc.or.jp
ICR LLC (In the US)
Bill Zima / Managing Partner Email: bill.zima@icrinc.com